NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Upperton Pharma Solutions offers services for the development of oral, nasal and pulmonary dosage forms. In this webinar, Dr Richard Johnson goes through the company’s process of developing the ...

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

Silgan Dispensing goes to great lengths to protect and preserve your formulation through state-of-the art engineering while making sure your customers can easily and reliably dispense the right dose.

Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked retinoschisis ...

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia ...

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain ...